Author:
Lan Li,Li Gang,Mehmood Muhammad Sajid,Xu Tingting,Wang Wei,Nie Qifan
Abstract
AbstractIn the future, novel and highly pathogenic viruses may re-emerge, leading to a surge in healthcare demand. It is essential for urban epidemic control to investigate different cities’ spatiotemporal spread characteristics and medical carrying capacity during the early stages of COVID-19. This study employed textual analysis, mathematical statistics, and spatial analysis methods to examine the situation in six highly affected Chinese cities. The findings reveal that these cities experienced three phases during the initial outbreak of COVID-19: “unknown-origin incubation”, “Wuhan-related outbreak”, and “local exposure outbreak”. Cities with a high number of confirmed cases exhibited a multicore pattern, while those with fewer cases displayed a single-core pattern. The cores were distributed hierarchically in the central built-up areas of cities’ economic, political, or transportation centers. The radii of these cores shrank as the central built-up area’s level decreased, indicating a hierarchical decay and a core–edge structure. It suggests that decentralized built environments (non-clustered economies and populations) are less likely to facilitate large-scale epidemic clusters. Additionally, the deployment of designated hospitals in these cities was consistent with the spatial distribution of the epidemic; however, their carrying capacity requires urgent improvement. Ultimately, the essence of prevention and control is the governance of human activities and the efficient management of limited resources about individuals, places, and materials through leveraging IT and GIS technologies to address supply–demand contradictions.
Funder
Northwest University, China
Publisher
Springer Science and Business Media LLC
Reference83 articles.
1. World Health Organization. Q&As on COVID-19 and Related Health Topics. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/question-and-answers-hub (2022).
2. Wilder-Smith, A., Chiew, C. J. & Lee, V. J. Can we contain the COVID-19 outbreak with the same measures as for SARS?. Lancet Infect. Dis. 20, e102–e107 (2020).
3. LopezBernal, J. et al. Effectiveness of Covid-19 vaccines against the B.1.617.2 (Delta) variant. N. Engl. J. Med. 385, 585–594 (2021).
4. Wang, C. & Han, J. Will the COVID-19 pandemic end with the Delta and Omicron variants?. Environ. Chem. Lett. 20, 2215–2225 (2022).
5. Allam, Z. & Jones, D. S. Pandemic stricken cities on lockdown. Where are our planning and design professionals [now, then and into the future]?. Land Use Policy 97, 104805 (2020).